Edetate calcium disodium is a metal ion chelator used to reduce blood concentrations and depot stores of lead from the body. It is on the World Health Organization Model List of Essential Medicines.
Edetate calcium disodium was granted FDA approval on 16 July 1953.
Edetate calcium disodium is indicated to reduce blood levels and depot stores of lead in acute and chronic lead poisoning.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.